Last 47 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 23.44 | 27.70 | 27.69 | 16.98 | 47.13 | 32.90 | 59.25 | 28.64 | 28.88 | 38.00 | 200.76 | 207.69 | — | — | — | — | — | — | — | — | — |
| — | -15.8% | -53.3% | -40.7% | +63.2% | -13.4% | -70.5% | -86.2% | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 7.17 | 4.47 | 4.08 | 3.43 | 5.30 | 4.92 | 3.79 | 3.89 | 3.67 | 2.53 | 2.42 | 2.98 | 2.02 | 1.21 | 1.10 | 1.70 | 2.89 | 2.49 | 4.52 | 3.74 | 4.11 |
| — | -9.1% | +7.7% | -11.9% | +44.5% | +94.4% | +56.4% | +30.4% | +81.7% | +109.7% | +121.0% | +75.6% | -30.1% | -51.5% | -75.7% | -54.6% | -29.7% | -58.4% | -10.7% | +26.0% | +52.3% | |
| P/B Ratio | 3.23 | 3.93 | 3.35 | 2.72 | 4.09 | 3.65 | 2.74 | 2.85 | 3.50 | 2.36 | 2.10 | 2.59 | 1.63 | 0.91 | 0.68 | 0.90 | 1.22 | 1.49 | 2.59 | 2.21 | 2.28 |
| — | +7.7% | +22.0% | -4.5% | +16.8% | +54.8% | +30.7% | +10.0% | +115.2% | +157.8% | +210.1% | +186.9% | +33.1% | -38.5% | -73.8% | -59.2% | -46.3% | -47.1% | +28.0% | -48.3% | -30.2% | |
| P/FCF | 76.85 | 14.25 | 157.72 | — | 122.26 | 5.54 | 11.02 | 17.27 | 39.40 | 50.56 | 8.98 | 13.25 | 19.91 | — | — | — | — | — | — | 13.22 | — |
| — | +157.0% | +1330.9% | — | +210.3% | -89.0% | +22.7% | +30.3% | +97.9% | — | — | — | — | — | — | — | — | — | — | +8.7% | — | |
| EV / EBITDA | 40.58 | 22.21 | 20.41 | 15.26 | 33.63 | 48.36 | 28.06 | 24.99 | 36.35 | 16.28 | 46.22 | 2.34 | 29.10 | — | — | — | — | — | — | — | — |
| — | -54.1% | -27.2% | -38.9% | -7.5% | +197.1% | -39.3% | +968.9% | +24.9% | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | 87.08 | 26.31 | 18.48 | 11.65 | 23.42 | 16.22 | 14.71 | 41.80 | 23.85 | 13.03 | 26.65 | 19.61 | — | — | — | — | — | — | — | — | — |
| — | +62.3% | +25.6% | -72.1% | -1.8% | +24.4% | -44.8% | +113.2% | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 75.4% | 74.6% | 75.2% | 76.4% | 75.2% | 75.2% | 74.6% | 74.6% | 73.5% | 75.3% | 74.9% | 74.6% | 74.3% | 73.2% | 73.0% | 71.3% | 74.1% | 72.6% | 76.6% | 77.5% | 76.1% |
| — | -0.8% | +0.7% | +2.5% | +2.3% | -0.2% | -0.4% | -0.1% | -1.1% | +2.9% | +2.7% | +4.6% | +0.4% | +0.9% | -4.7% | -7.9% | -2.6% | -10.8% | +0.6% | -0.4% | +1.0% | |
| Operating Margin | 8.3% | 14.0% | 12.9% | 13.2% | 9.3% | 4.6% | 5.0% | 3.8% | 2.7% | 5.9% | 1.0% | 111.9% | -1.6% | -17.2% | -55.4% | -71.7% | -94.2% | -25.1% | -18.6% | -17.1% | -15.3% |
| — | +205.5% | +158.6% | +248.8% | +246.6% | -21.9% | +388.3% | -96.6% | +267.0% | +134.1% | +101.8% | +256.1% | +98.3% | +31.6% | -197.7% | -318.0% | -516.1% | -16.1% | -42.1% | -197.6% | -57.0% | |
| Net Margin | 14.6% | 15.8% | 14.7% | 20.2% | 11.6% | 16.0% | 9.6% | 13.6% | 6.3% | 6.0% | 1.2% | 1.4% | -2.8% | -21.2% | -36.7% | -64.1% | -97.5% | -30.6% | -25.0% | -15.9% | -22.4% |
| — | -1.3% | +53.7% | +48.7% | +83.9% | +167.6% | +686.2% | +864.2% | +327.5% | +128.2% | +103.3% | +102.2% | +97.2% | +30.6% | -46.7% | -303.0% | -335.7% | -10.6% | -11.5% | -176.8% | -39.3% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.3% | 3.6% | 3.1% | 4.1% | 2.3% | 3.1% | 1.8% | 2.9% | 1.5% | 1.4% | 0.3% | 0.3% | -0.6% | -3.9% | -5.5% | -8.2% | -9.8% | -4.5% | -3.5% | -2.3% | -3.1% |
| — | +15.7% | +75.0% | +40.6% | +48.9% | +117.7% | +561.3% | +849.0% | +373.1% | +135.8% | +104.8% | +103.7% | +94.3% | +11.9% | -56.1% | -251.8% | -221.1% | -39.9% | -4.0% | -13.5% | +35.8% | |
| ROA | 7.4% | 2.3% | 2.0% | 2.6% | 1.4% | 1.9% | 1.1% | 1.9% | 1.0% | 0.9% | 0.2% | 0.2% | -0.4% | -2.7% | -3.8% | -5.9% | -7.2% | -3.4% | -2.7% | -1.8% | -2.4% |
| — | +20.5% | +75.0% | +39.5% | +45.0% | +108.6% | +556.8% | +799.2% | +348.7% | +133.4% | +104.5% | +103.5% | +94.7% | +18.8% | -43.7% | -225.5% | -197.6% | -31.3% | -7.3% | -51.5% | +12.5% | |
| ROIC | 59.3% | 7.6% | 8.3% | 15.4% | 14.8% | 21.3% | — | — | — | 3.0% | 0.2% | 52.5% | — | — | — | — | -697.7% | -7.0% | -2.7% | -2.6% | -2.1% |
| — | -64.2% | — | — | — | +599.6% | — | — | — | — | — | — | — | — | — | — | -32849.6% | -45.1% | +85.7% | +68.5% | +82.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.09 | 0.09 | 0.09 | 0.09 | 0.10 | 0.09 | 0.09 | 0.09 | — | 0.10 | — | 0.01 | — | — | — | 0.01 | — | — | — | 0.01 | — |
| — | +0.1% | +1.4% | +3.2% | — | -11.5% | — | +696.8% | — | — | — | +5.4% | — | — | — | -18.3% | — | — | — | -61.6% | — | |
| Debt / EBITDA | 1.16 | 2.48 | 2.71 | 3.01 | 4.07 | 6.35 | 5.74 | 4.94 | — | 4.94 | — | 0.05 | — | — | — | — | — | — | — | — | — |
| — | -61.0% | -52.7% | -39.1% | — | +28.5% | — | +10845.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 3.83 | 3.59 | 3.34 | 3.83 | 3.19 | 3.51 | 5.03 | 5.19 | 4.52 | 4.70 | 4.48 | 5.68 | 6.36 | 6.98 | 6.13 | 7.14 | 6.85 | 7.71 | 7.89 | 7.22 | 8.37 |
| — | +2.4% | -33.6% | -26.2% | -29.4% | -25.4% | +12.3% | -8.6% | -28.9% | -32.7% | -26.9% | -20.4% | -7.1% | -9.4% | -22.3% | -1.1% | -18.2% | -16.7% | -18.9% | +102.0% | +142.3% | |
| Quick Ratio | 3.51 | 3.27 | 3.04 | 3.51 | 3.02 | 3.34 | 4.75 | 4.90 | 4.23 | 4.39 | 4.18 | 5.30 | 5.94 | 6.54 | 5.61 | 6.66 | 6.48 | 7.43 | 7.70 | 7.20 | 8.37 |
| — | -2.2% | -36.0% | -28.4% | -28.6% | -23.9% | +13.7% | -7.5% | -28.8% | -32.8% | -25.5% | -20.4% | -8.4% | -12.0% | -27.2% | -7.4% | -22.6% | -19.8% | -20.8% | +105.1% | +142.3% | |
| Interest Coverage | 4.45 | 2.72 | 8.55 | 6.85 | 4.17 | 3.67 | 3.16 | 3.91 | 2.97 | 2.75 | 1.66 | 7.78 | -0.62 | -1.56 | — | -210.36 | -49.19 | -6.10 | -4.57 | -3.83 | -3.42 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BWAY stock.
BrainsWay Ltd.'s current P/E is 23.4x. The average P/E over the last 4 quarters is 29.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
BrainsWay Ltd.'s current operating margin is 8.3%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking BrainsWay Ltd.'s business trajectory between earnings reports.